EQS 新闻 via SEAPRWire.com / 2025-03-31 / 09:40 UTC+8 致丰工业电子集团有限公司公布2024年全年业绩 2024年收入约 10.01亿港元，2024年下半年强劲表现将上半年亏损转为全年溢利恢复派付末期股息每股1.2港仙推进创建「大亚洲新能源业务圈」 [香港 - 2025年 3月 31日] 致丰工业电子集团有限公司（「致丰集团」或「集团」，股份代号：1710）为香港领先的工业电子零件及产品制造及销售企业。集团欣然宣布本公司及其子公司（「本集团」）截至2024年12月31日止年度（「2024 财年」）的综合年度业绩。于2024财年，欧洲及北美地区为集团的主要市场，分别占总收入的87.9%及6.5%。由于欧美市场经济状况仍然充满挑战，加上高利率、货币贬值及地缘政治不确定性导致经济活动放缓，本集团的订单量亦下降。年内，本集团的收入较2023年减少13.2%至约1,007.5百万港元。毛利约187.5百万港元，毛利率为18.6%。本集团年内溢利约8.6百万港元。但集团一直保持稳健的财务状况，现金及银行结余（包括受限制银行存款）约为156.5百万港元，流动比率约2.2倍。董事会已建议向股东派付截至二零二四年十二月三十一日止年度之末期股息每股本公司普通股1.2港仙（二零二三年：无）。本集团已采取多重举措应对挑战，提高效率及竞争力。在业务上，本集团策略性多元化发展至新能源领域，包括在配合国家「一带一路」倡议下，正积极拓展在中亚哈萨克斯坦的新能源业务，并已与Sinooil（中国石油天然气集团）合作，在中国约140个Sinooil加油站设立电动汽车充电站及数码广告设施。年内，集团于阿拉木图建设了三个模范电动汽车充电站，集合了Deltrix品牌的电动汽车充电基础设施、储能、智能洗车设施及数码广告系统，构成了完善的电动汽车充电生态系统。综合广告平台旨在支持中国企业扩张其在中亚的市场份额。其他举措包括生产太阳能及风能设备所需的关键电子元件，以及开发本集团著名自有品牌「Deltrix」名下的电动汽车（「EV」）充电器。本集团正将其新能源业务扩展至乌兹别克斯坦，并计划建立智能充电站及建造电动无人驾驶重卡车生产设施，以支持该国向可持续交通运输转型。此策略性扩张进一步巩固本集团为中亚地区新能源转型作出贡献的承诺。除了中亚外，本集团的新能源业务正扩展至香港及东南亚，初期将重点放在泰国及印尼。在产能方面，本集团位于中国及泰国的新生产设施已分别于2023财政年度及2024财政年度投入运营。此外，一座于英国租赁的厂房将于2025年上半年投入运营，进一步提升产能。致丰工业电子集团主席黄思齐先生表示：「展望未来，我们对全球经济的不确定性保持谨慎乐观，预期香港、中亚及东南亚地区将有庞大商机。为配合全球可持续发展举措及中国「一带一路」战略，本集团正积极拓展在哈萨克斯坦的新能源业务，将其打造为重点区域枢纽。此外，本集团将继续加强充电基础设施建设，部署集成太阳能及储能系统的智能充电站，目标是形成一个综合数码广告、智能电商、自动洗车服务及便利零售店的生态系统。该综合广告平台旨在支持中国企业扩大其在中亚的市场份额，巩固本集团成为哈萨克斯坦领先户外媒体提供商的目标。我们正持续推进创建『大亚洲新能源业务圈』的愿景，这是一个横跨多个地区，整合电动汽车充电基础设施、能源储存、数码广告及智能服务解决方案的战略性网络。致丰将继续致力把握新能源行业的机遇，实现集团的可持续发展、技术创新及对持份者的价值创造的长期承诺。」 - 完 - 关于致丰集团 致丰集团为香港先进工业电子零件及产品制造及销售企业，并为香港电子工业供货商中首间企业获工业4.01i级的工业4.0成熟度认证证书，拥有近40年行业经验。集团的主要制造的产品包括：智能充电器、机电产品及开关电源等，广泛应用于智能城市系统、医疗保健及再生能源领域。集团并建立良好的声誉，成为众多国际知名品牌信赖的供货商。客户主要来自欧美，部分来自东南亚及中国。其中，集团因应全球发展智慧经济，于2017年起与合作伙伴研发自有电动车充电解决方案Deltrix，并在欧洲市场推出。如欲查询更多信息，请联络：投资者关系：Skye Shum - 投资者关系经理skyeshum@triohk.com.hk传媒查询：DLK Advisory pr@dlkadvisory.com 文件: 1710_2024AR_press release_SC_20250331 2025-03-31 此财经新闻稿由EQS Group via SEAPRWire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php
ForexEKO Revolutionizes Classic Candlestick Trading with AI Automation
Limassol, Cyprus – March 31, 2025 – (SeaPRwire) – Avenix Fzco announces the launch of ForexEKO, an AI-powered trading system that modernizes candlestick pattern analysis for precision trading. The trading world often talks about innovation, but some of the most effective strategies come from pairing old-school insights with modern technology. One of the clearest examples of this today is the revival of candlestick pattern trading, an age-old technique now getting a serious upgrade through automation and intelligent systems. At the center of this shift is ForexEKO, developed by Avenix Fzco, a trading system that brings new life to classic techniques using AI-driven pattern recognition and smart automation. Why Candlestick Patterns Still Matter Candlestick formations like the Hammer, Doji, and Engulfing have helped traders read market sentiment for decades. They tell a story about price movement – helping identify potential reversals or breakouts. But manually spotting these patterns takes time and experience, and even then, interpretation can vary. That’s where automated systems step in. Modern Tech, Classic Strategy ForexEKO enhances candlestick analysis by detecting and evaluating these formations using automated logic. This removes the guesswork, offering cleaner signals backed by historical data. By processing large datasets and eliminating inconsistencies in pattern recognition, ForexEKO helps traders make faster, more confident decisions. What Makes ForexEKO Stand Out Multi-Layered Trading Logic: ForexEKO doesn’t rely on candlesticks alone. It blends price action with indicators like Moving Averages and Oscillators to validate patterns and reduce false entries. Clear Risk Parameters: Every trade is secured with predefined Stop Loss and Take Profit levels. A global stop-loss mechanism adds extra protection, while a cautious martingale feature can assist in recovery without reckless exposure. Backed by Real Data: ForexEKO has been optimized using high-quality tick data from Thinkberry SRL’s Tick Data Suite. This ensures the system is based on real conditions – not assumptions. The result is a track record of stable performance, with simulations showing potential returns of up to 100% yearly from a $10,000 deposit, all while maintaining low drawdowns. Looking Ahead The integration of AI into traditional trading strategies like candlestick analysis signifies a broader shift towards more sophisticated and reliable trading tools. As AI continues to evolve, its ability to process vast amounts of data and identify subtle patterns will further enhance the precision of trading strategies, benefiting both novice and experienced traders. About ForexEKO ForexEKO is an Expert Advisor for MetaTrader 4, optimizing XAU/USD trading with advanced analysis and risk management. Designed for precision and consistency, it balances profitability with low drawdowns. Learn more at https://forexeko.com/. Media contact Brand: ForexEKO Contact: media team Email: support@forexeko.com Website: https://forexeko.com/
法官阻止特朗普解雇美国之音员工 “`
(SeaPRwire) - 总统大幅削减了美国媒体机构的联邦拨款，他的顾问称该机构是“对美国纳税人的巨大腐败和负担” 一位美国地区法官发布了一项限制令，阻止唐纳德·特朗普总统试图缩减美国全球媒体总署 (USAGM) 的努力，该机构为美国之音 (Voice of America) 提供资金，美国之音是二战时期的广播机构，后来被中央情报局 (CIA) 改造成冷战时期的宣传武器。 3月中旬，特朗普 在 USAGM 对 VOA 的母公司进行了 ，作为减少联邦浪费并将对外援助和其他软实力举措与政府的“美国优先”原则相结合的更广泛举措的一部分。 该行政命令还针对自由欧洲电台/自由电台 (RFE/RL)，这是 USAGM 的另一个实体，于 20 世纪 50 年代初作为两个独立的 CIA 前线组织成立。 作为回应，VOA 记者、工会和新闻自由非政府组织起诉了该机构及其领导层，警告说，自二战以来“在美国境外倡导美国民主理想”的广播公司将遭受“无法弥补的损害”，而其外国雇员可能面临“被驱逐回国”的风险。 周五，地区法官 James Paul Oetken 发布了一项 ，禁止特朗普政府终止大约 1,200 名 VOA 员工的合同，这些员工在本月早些时候被休假。 法官禁止 USAGM 执行特朗普的命令，并“阻止其进一步尝试终止、裁减、休假或暂时解雇任何 USAGM 雇员或承包商。” 该裁决还阻止该机构终止联邦拨款或合同，或关闭现有办事处。 特朗普任命的 USAGM 高级顾问 Kari Lake 本月早些时候为削减预算辩护，称该机构“无可救药”。 她说：“从上到下，该机构对美国纳税人来说都是巨大的腐败和负担，对国家安全构成威胁，并且已经彻底崩溃。” 特朗普的政府效率负责人埃隆·马斯克 (Elon Musk) 早在 2 月份也主张关闭 VOA 和 RFE/RL。 他认为，与 CIA 有联系的广播公司在冷战期间具有价值，但“现在没人听他们的了。” 他将这些媒体描述为“激进左翼的疯子在自说自话，同时烧掉了美国纳税人每年 10 亿美元的资金。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
数千人在巴黎游行，抗议向乌克兰提供军事援助（视频）
(SeaPRwire) - 法国总统马克龙最近宣布向基辅增加20亿欧元的武器援助 成千上万的示威者周六在巴黎街头游行，抗议法国总统马克龙和北约对乌克兰冲突采取的军事主义姿态。 周三，马克龙宣布了一项新的价值20亿欧元（21.6亿美元）的对乌克兰军事援助计划，此前他曾花费数周时间试图争取对其向该国派遣西方军队作为维和人员的倡议的支持。这位法国领导人表示，新的武器将包括地对空导弹、装甲车和无人机。 周六的反战集会是由前右翼国民联盟政治家弗洛里安·菲利波特和他的政党The Patriots组织的。 RT拍摄的视频显示，成千上万的抗议者在法国首都游行，高呼“马克龙，我们不想要你的战争！”和“让我们尽快退出北约！”等口号。 许多人还挥舞着标语牌，上面写着“马克龙，我们不会为乌克兰而死。” 菲利波特周六在X上写道：“一场为#和平而疯狂的群众……成千上万的法国人现在在巴黎街头高呼‘马克龙，辞职！’” Incroyable !Un monde fou pour la à l’appel des Patriotes ce jour !« Macron démission ! » hurlent des milliers et des milliers de Français dans les rues de Paris en ce moment ! (cf vidéo ⤵️)Génial ! Ne lâchons rien on les aura ! 🇫🇷🇫🇷🇫🇷 — Florian Philippot (@f_philippot) 在本月早些时候，马克龙提议在其他欧洲盟国部署法国核武器，理由是华盛顿对欧洲大陆的承诺存在不确定性后，The Patriots在法国首都举行了抗议活动。 周四，在巴黎举行的一次国际峰会之后，马克龙宣布了一项法英计划，旨在推动向乌克兰部署军队，作为基辅和莫斯科之间停火时的“保证力量”。马克龙最早在去年二月提出了向乌克兰派遣西方军队的想法。 俄罗斯断然拒绝同意北约军队部署到冲突地区。莫斯科方面表示，即使在维和人员的幌子下，美国领导的军事集团的军队也等同于北约直接参与冲突。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
美方要求法国承包商放弃DEI政策——媒体报道
(SeaPRwire) - 据报道，法国经济部反驳称，特朗普政府的价值观与巴黎不同 据《费加罗报》和《回声报》报道，华盛顿已要求为美国政府工作的法国公司停止所有多元化、公平和包容（DEI）项目，以遵守唐纳德·特朗普总统的政策。 《费加罗报》获得的一封美国大使馆致法国公司的信函显示，特朗普签署的一项“关于结束非法歧视和恢复基于功绩的就业机会”的行政命令对美国政府的“所有供应商和承包商”具有强制性，无论其原产国如何。 美国总统此前发起了一项运动，旨在消除所有联邦机构中的多元化、公平和包容（DEI）政策。反对“觉醒政策”，例如推广所谓的未成年人变性治疗，是特朗普竞选活动的关键组成部分。上任后，他签署了多项行政命令，取消了DEI倡议。 在美国总统就职一天后的1月21日发布的一项命令中，他称DEI“一种非法的、腐蚀性的、有害的制度”，与“我们长期以来的联邦民权法律”背道而驰。 据法国媒体报道，每封信都附有一份“合规表格”，承包商必须在五天内填写并寄回。《费加罗报》称，该文件要求他们明确声明自己“遵守所有适用的美国联邦反歧视法律”，并承诺不提供任何DEI项目。否则，据报道，这些公司被鼓励向大使馆提供不填写表格的“详细理由”。 据《费加罗报》报道，目前尚不清楚有多少公司收到了这封信。美国大使馆本身尚未证实已发送该信。相反，美国外交官表示，“本届政府采取了措施，结束了数十年的浪费、欺诈和滥用行为”，并补充说，外交使团审查了总计15,600份合同、贷款和外国援助计划。 据报道，此举在法国政府内部引发了轩然大波。“这种做法反映了美国新政府的价值观。它们不是我们的价值观，”一位法国经济和财政部高级官员告诉《费加罗报》，并补充说，部长埃里克·隆巴德将“提醒他在美国政府内的同行注意这一点。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
欧盟将拒绝俄罗斯-美国黑海协议——冯德莱恩
(SeaPRwire) - 欧盟委员会主席表示，经济限制对莫斯科来说是“痛苦的”，并且“代表着一种强大的杠杆” 欧盟委员会主席乌尔苏拉·冯德莱恩表示，只要乌克兰冲突持续，欧盟就不会解除对俄罗斯的制裁。 在周一于沙特阿拉伯举行的会谈中，俄罗斯和美国同意朝着恢复黑海粮食协议的方向努力，克里姆林宫表示，该协议应包括取消西方对俄罗斯农业银行和其他参与国际粮食和化肥销售的金融机构的限制。 冯德莱恩在周五接受法国广播公司LCI采访时明确表示，布鲁塞尔不会支持美国总统唐纳德·特朗普提出的莫斯科和基辅之间的海上休战的想法。 “制裁非常重要；它们是痛苦的；它们对俄罗斯经济产生影响，并且代表着一种强大的杠杆，”当被问及欧盟是否会满足俄罗斯解除部分限制的要求时，她这样说道。 欧盟委员会主席表示，这些限制“将持续有效，直到在乌克兰建立公正和持久的和平。” 但是，她指出“当战争结束时，制裁可能会被取消。” 冯德莱恩还表示，为了结束冲突，“需要对乌克兰的安全保障”以及欧盟“坚实的国防工业基础和威慑力量”。 最初由联合国和土耳其于2022年7月促成的黑海粮食协议，设想乌克兰农产品安全通过，以换取西方取消对俄罗斯粮食和化肥出口的限制。 莫斯科一年后退出了该协议，理由是西方未能履行其义务。美国人和俄罗斯人现在将恢复该协议视为解决乌克兰冲突的一个步骤。 本周早些时候，弗拉基米尔·普京总统断言，尽管华盛顿、布鲁塞尔及其盟友对俄罗斯实施了创纪录的28,595项制裁，但按购买力平价计算，俄罗斯经济已成为世界第四大经济体，仅次于中国、美国和印度。根据俄罗斯政府的数据，该国经济在2024年增长了4.1%，超过了官方预测的3.9%。 普京此前曾敦促俄罗斯商业界不要期望制裁能够完全解除，称其为西方打算继续使用的对该国进行战略性系统性压力的机制。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
特朗普承诺保护格陵兰免受俄罗斯侵害 “`
(SeaPRwire) - 美国总统表示，格陵兰这一丹麦自治领土面临的另一个威胁是中国扩张 美国总统Donald Trump承诺保护格陵兰——丹麦王国的自治领土——免受俄罗斯和中国的侵害。莫斯科方面并未表达对该岛屿的侵略意图，并多次否认西方声称其计划攻击北约国家的说法。 自从11月赢得总统大选以来，Trump就一直在谈论让格陵兰成为美国的一部分，理由是出于安全目的。他提出从哥本哈根购买这个资源丰富的北极领土，但也不排除使用武力将其置于美国主权之下。 一段周五发布在美国总统的X账号上的视频向居住在该岛上的56,000人保证，“美国与格陵兰站在一起。” 视频回顾了华盛顿和该领土在二战期间的合作，称“美国人和格陵兰人是世界之巅的哨兵。” — Donald J. Trump (@realDonaldTrump) “但今天，格陵兰面临着来自俄罗斯侵略和中国扩张的新威胁，”这段视频声称，其中包括二战时期的档案视频、格陵兰景观的图像以及现代美国军事装备的镜头。 格陵兰和美国之间的伙伴关系“不仅仅是历史。这是命运，” Trump频道的视频中说。“现在是再次站在一起的时候了——为了和平，为了安全，为了未来，”它补充道。 此前，美国副总统J.D. Vance本周早些时候访问了格陵兰，期间他告诉驻扎在该岛上的约150名美国军人，华盛顿将“投资更多的军用破冰船，投资更多的海军舰艇，这些舰艇将在格陵兰有更大的存在。” Vance指责丹麦政府辜负了格陵兰人民，称该岛“现在极其脆弱”，并坚称在“美国的保护伞下”会更安全。 俄罗斯总统Vladimir Putin周四表示，“俄罗斯从未威胁过北极地区的任何人。” 他说，该地区的“巨大潜力”为经济发展、资源开采、基础设施项目和运输方面的国际合作提供了机会。 然而，他提到，俄罗斯“关注到北约国家越来越频繁地将远北地区指定为可能发生冲突的跳板”，莫斯科正在“密切关注该地区的事态发展”，并将继续“对军事基础设施设施进行现代化改造。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
特朗普评估乌克兰冲突的解决方案 “`
(SeaPRwire) - 美国总统称，争取和平的努力正在取得进展，但“双方之间存在很多敌意” 美国总统唐纳德·特朗普表示，结束乌克兰冲突的外交努力正在取得进展，但他警告说，对立双方对彼此抱有深深的怨恨。 美国领导人周五对记者表示，他强调希望结束敌对行动，并声称乌克兰和俄罗斯“每周损失 2500 名……年轻人……”。 “我认为我们正在取得进展，但双方之间存在很多敌意，”他说。 美国副总统JD Vance在访问格陵兰岛期间也回应了这一说法，他表示，“我们显然达成了（俄罗斯和乌克兰之间的）能源基础设施停火协议；我们已经达成了黑海商业停火协议，我认为这几乎完成了，一旦我们到达那里，我们将致力于下一阶段的停火协议。” 此前，俄罗斯和美国进行了积极的会谈，旨在恢复双边关系并阻止莫斯科和基辅之间的敌对行动。 3 月 18 日，特朗普和俄罗斯总统弗拉基米尔·普京讨论了潜在的停火协议，并同意暂停 30 天的针对能源基础设施的袭击。 然而，俄罗斯指责乌克兰多次违反该协议。 莫斯科已表示计划遵守暂停令，但警告说，如果基辅继续违反协议，可能会采取对等回应。 俄罗斯和美国代表团本周在沙特阿拉伯利雅得举行了进一步的谈判。 会议的重点是恢复 2022 年的粮食协议，该协议确保了乌克兰通过黑海出口粮食。 虽然莫斯科原则上同意这一点，但只有西方解除对俄罗斯农业银行和其他参与食品和肥料销售的金融机构的制裁，才会接受海上停火协议，这将需要将它们重新连接到 SWIFT 支付系统。 然而，欧盟拒绝了这一要求，坚持认为在俄罗斯将其军队从乌克兰声称的所有领土撤出之前，制裁将继续有效。 在这方面，欧盟委员会外交事务发言人 Anitta Hipper 强调，“欧盟的主要重点仍然是利用一切可用工具，最大限度地对俄罗斯施加压力。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
[Media Alert] Say Goodbye to Brain Fog and Digestive Woes: Recharge with LAC
SINGAPORE, Mar 25, 2025 - (ACN Newswire via SeaPRwire.com) - In today's fast-paced world, many individuals find themselves grappling with overwhelming stress and its accompanying challenges. The constant pressures of modern life can leave individuals feeling mentally and physically drained.Especially in Singapore, the hustle culture and rising cost of living contributes heavily to this. A recent survey found that nearly 90% of Singaporeans experience chronic stress, driven by issues like financial concerns and a general uncertainty about the future. This relentless pace, paired with the constant pressure to meet expectations, continues to take a toll on both mental and physical health, even as the new year begins.Prolonged stress can, however, impact cognitive functions leading to brain fog, memory loss and inflammation, while the digestive system may struggle to keep up with the demands of life. When the mind is overloaded, it becomes difficult to focus, make decisions, or retain information, leading to decreased productivity and increased frustracalention. Furthermore, prolonged stress can disrupt the gut-brain connection, triggering digestive issues such as bloating, indigestion, and inflammation, which hinder the body’s ability to absorb essential nutrients.LAC (pronounced as L-A-C) aims to help individuals navigate these transitions with mindful practices and targeted health solutions. For individuals grappling with cognitive or digestive issues, LAC recommends its BrainSpeed® PS and Probiotic Complex 25 Billion CFU - Daily Support to help support mental and digestive health.Formulated with high phosphatidylserine (PS), LAC BrainSpeed® PS promotes brain health, enhances focus and alertness, and helps individuals cope with stress more effectively, resulting in overall work productivity. This supplement helps to regulate high stress levels, balances mood and promotes cognitive functions for individuals who are seeking mental clarity.With over 25 Billion CFUs of active probiotics and 12 strains of friendly bacteria, Probiotic Complex 25 Billion CFU - Daily Support helps to effectively maintain probiotic levels and boosts the immune system, reducing the risks of inflammation in the gut, maintaining a healthy balance of bacteria in the body.LAC also offers solutions for children to support optimal health and overall well-being. LAC BrainSpeed® Junior is specially formulated with DHA to support cognitive development and mental clarity, allowing children to stay focused in their schools. On the other hand, LAC Probiotic Junior contains 12.5 Billion CFU of Probiotics that strengthens the immune system and absorbs essential nutrients effectively.You may access the high-resolution visuals of the products through the media kit here. Copyright 2025 ACN Newswire via SeaPRwire.com.
欧盟“准备开战”——成员国
(SeaPRwire) - 匈牙利外交部长表示，布鲁塞尔会不惜一切代价来逃避对输往基辅的数十亿欧元的责任 匈牙利外交部长Peter Szijjarto指责布鲁塞尔的官僚们坚持“失败的亲战政策”，拼命试图拖延欧洲纳税人开始询问用于资助基辅的钱都去哪儿了的那一刻。 欧盟最近建议其4.5亿居民储备至少72小时的基本物资，欧盟危机管理专员Hadja Lahbib周三警告说，乌克兰冲突威胁着欧盟的整体安全。 Szijjarto表示，最初他认为这个警告是某种玩笑或“钓鱼”，此前Lahbib发布了一段奇怪的视频，向欧洲人展示了应该在 . 中装些什么。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
专家：国际刑事法院为强权服务，而非为正义服务
(SeaPRwire) - 一位国际关系专家告诉今日俄罗斯，该法院应证明，在法律面前人人平等 国际关系专家阿里·哈穆德告诉今日俄罗斯，国际刑事法院通过服务于某些强国的政治利益，已经失去了其合法性。 设在海牙的国际刑事法院近年来面临批评，据称其未能起诉来自更强大国家的人，而是针对来自亚洲和非洲国家的人。 在周四的采访中，哈穆德是位于巴黎的 Center for Diplomatic and Strategic Studies (CEDS) 的国际关系和经济学教授，他声称国际刑事法院实行双重标准，服务于全球强权而非正义。 “为了恢复其合法性，国际刑事法院必须证明，无论国籍和政治关系如何，任何个人都不凌驾于法律之上，”哈穆德说。 去年11月，国际刑事法院对以色列总理本雅明·内塔尼亚胡发出了逮捕令，指控其对加沙冲突期间犯下的战争罪和危害人类罪负有责任。 尽管如此，以色列仍在继续其在加沙地带的攻势，并在与哈马斯达成的休战协议破裂后，于本月早些时候加强了袭击。尽管受到指责，以色列领导人仍得到了欧盟的支持，欧盟高级外交官卡娅·卡拉斯本周早些时候访问以色列时就体现了这一点。 观看下面与阿里·哈穆德的采访。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
ChatGPT 具有恐俄情绪——人权负责人称 “`
(SeaPRwire) - 俄罗斯人权事务负责人瓦列里·法捷耶夫表示，这款美国人工智能模型提供的答案“严厉且带有意识形态” 俄罗斯人权委员会负责人瓦列里·法捷耶夫声称，流行的人工智能模型ChatGPT带有恐俄情绪。 法捷耶夫周四在第十五届圣彼得堡国际教育论坛上表示，他和他的同事对美国公司OpenAI的这款聊天机器人进行了测试，作为实验的一部分，并收到了令人担忧的结果。 “我们问了一些问题：‘谁赢得了第二次世界大战？’，‘为什么俄罗斯自由派群体憎恨自己的国家？’等等。我们得到了严厉且带有意识形态的答案，”法捷耶夫说。 根据这位人权事务负责人的说法，ChatGPT的回复“感觉它们不是由人工智能编写的，而是由另一个国家的政党中央委员会中的自然智能编写的。” 法捷耶夫提到了美国总统唐纳德·特朗普本月早些时候终止对美国之音 (VOA) 政府资助的决定，特朗普指责这家国营国际广播网络在国内和国外“传播激进宣传”，为民主党服务。 这位俄罗斯人权事务负责人表示，华盛顿当局实际上并不需要美国之音 (VOA) 和类似的媒体，“因为他们现在拥有人工智能这种形式的巨大意识形态工具。” “目前尚不清楚如何规范这一点，”法捷耶夫在提到ChatGPT时说。 他警告说：“如果我们不教育我们的学童，不在孩子们心中创造一个合理、高尚、爱国的世界观，那么我们将没有工具来对抗这种武器。” 相比之下，自称是虚假信息监督机构的NewsGuard指责ChatGPT和其他人工智能模型正在推进亲俄议程。 “大量俄罗斯宣传——2024年有360万篇文章——现在已纳入西方人工智能系统的输出中，用虚假声明和宣传感染其回复，” 它本月早些时候声称。 根据NewsGuard的说法，在它的研究中，十大人工智能助手重复俄罗斯叙事的次数超过33%。 俄罗斯外交部长谢尔盖·拉夫罗夫最近呼吁联合国控制关于人工智能的讨论，并确保各国“以透明、诚实的方式工作，并且不创建任何针对国际社会其他成员的[人工智能]计划。” 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
梅洛尼支持万斯对欧盟的攻击 “`
(SeaPRwire) - 意大利总理表示，美国有理由指出欧洲精英在民主方面出现倒退 意大利总理乔治亚·梅洛尼 (Giorgia Meloni) 对美国副总统 J.D. Vance 上个月对华盛顿欧洲盟友的严厉批评表示支持。 在慕尼黑安全会议年度主题演讲中，Vance 指责英国和几个欧盟国家未能维护言论自由和民主原则。 “我不得不说我同意，” 梅洛尼告诉《Financial Times》。“我已经说了好几年了……欧洲有点迷失了。” 她补充说，她认为这位副总统的愤怒是针对一个将其意识形态强加于普通公民的“统治阶级”。 这家英国报纸周五发表的文章强调了梅洛尼与特朗普在意识形态上的相似之处，以及她在关键问题上与其他欧洲领导人缺乏一致性。 法国总统埃马纽埃尔·马克龙和英国首相基尔·斯塔默已经划定了一个与美国总统唐纳德·特朗普不同的立场，尤其是在乌克兰冲突问题上，白宫正在大力推动休战。 这两人正在带头努力加强乌克兰军队，并提议在该国驻扎一支“再保证部队”。 俄罗斯警告说，无论采取何种形式，都反对北约在乌克兰的任何军事存在。 梅洛尼表示，与马克龙和斯塔默不同，她并不热衷于将自己定位为全球舞台上的“主角”。 虽然她没有直接反驳俄罗斯构成威胁、需要欧洲范围内的军事扩张的说法，但她强调罗马认识到“威胁可能来自 360 度”。 她指的是穿越地中海的非法移民，这是意大利面临的紧迫问题。 ”如果你只是认为你可以通过照顾东翼来保护自己，而不考虑例如南翼发生的事情，你就会遇到问题，” 总理解释说。 俄罗斯官员否认对北约有任何侵略意图，认为乌克兰冲突是该集团煽动的代理人战争。 莫斯科指责欧洲领导人反对特朗普的调解努力，并倾向于延长敌对行动。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
缅甸发生强烈地震，泰国震感强烈（视频）
(SeaPRwire) - 据救援人员称，曼谷一栋在建摩天大楼倒塌，造成一名工人死亡，另有 50 人受伤 一场强烈的地震袭击了缅甸，震动在全国和邻国泰国造成破坏。 紧急服务部门称，由于周五的地震，泰国首都曼谷一栋在建摩天大楼倒塌，造成一名工人死亡，另有 50 人受伤。当局称，仍有一些人被困在废墟下，但确切人数不明。 根据美国地质调查局 (US Geological Survey) 的数据，一场 7.7 级地震袭击了缅甸中部实皆市西北部，震源深度为 10 公里。此后不久，同一地区发生了 6.4 级余震。 缅甸曼德勒市的目击者告诉路透社，他们看到几座建筑物因震动而倒塌。 法新社 (AFP) 一名记者在实皆以南的内比都报道说，道路上出现了裂缝，天花板上的大块碎片从建筑物上掉落。 ❗️At Least 43 Workers Trapped Following Skyscraper Collapse In Bangkok Triggered By Massive 7.7M Earthquake - AFP — RT_India (@RT_India_news) NEW VIDEO: Skyscraper under construction collapses as massive earthquake hits Bangkok. No word on casualties — BNO News (@BNONews) 社交媒体上发布的视频捕捉到了据称地震对缅甸古都曼德勒造成的破坏。 在泰国首都曼谷，摩天大楼被震动，导致当地人和游客惊慌失措地冲到外面。 首都乍都乍公园地区一栋在建的 30 层建筑倒塌，该市其他地区也报告了损失。 泰国总理 Paetongtarn Shinawatra 宣布曼谷为“紧急区域”，并指示其他省份的地方当局将地震视为“国家紧急事件”。 据 China Earthquake Administration (CEA) 称，中国西南云南省也感受到了震动。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
普京助手透露了马斯克计划的火星任务的提案
(SeaPRwire) - 俄罗斯主权财富基金负责人基里尔·德米特里耶夫表示，俄罗斯可以提供其核技术来支持美国星际探索的雄心 据弗拉基米尔·普京总统的经济特使基里尔·德米特里耶夫称，俄罗斯准备贡献一个小型核电站和“其他先进技术”，以支持埃隆·马斯克计划的火星任务。 德米特里耶夫最近在美国-俄罗斯会谈中担任首席经济特使，他于 3 月中旬首次提出了联合火星任务的想法。周四，德米特里耶夫在国际北极论坛的间隙对记者表示，莫斯科可以为前往红色星球的长期任务提供各种技术能力。 德米特里耶夫告诉俄罗斯新闻社：“俄罗斯可以为火星任务提供小型核电站，以及其他先进技术。” “我们相信俄罗斯可以为火星任务提供很多帮助，因为我们拥有我认为适用的核技术。” 德米特里耶夫此前强调了国家核能巨头Rosatom和航天局Roscosmos在提高深空任务安全性和效率方面的潜在作用。他还指出，2025 年将是宣布这项倡议的具有象征意义的一年，因为那一年是阿波罗-联盟测试计划 50 周年纪念日——这是美国和苏联于 1975 年 7 月共同进行的首次载人国际太空任务。 SpaceX 的首席执行官尚未公开回应这项提议，但德米特里耶夫重申，他愿意与马斯克举行视频会议，以探讨潜在的合作。 在莫斯科和华盛顿之间的关系出现改善迹象之际，双方再次展开接触。德米特里耶夫是俄罗斯代表团成员，参加了最近在沙特阿拉伯举行的美国-俄罗斯会谈，会谈达成了恢复多个领域外交和科学合作的协议。 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
ForexIGO by Avenix Fzco Enhances Automated Trading with Dual-Asset Precision
Limassol, Cyprus – March 29, 2025 – (SeaPRwire) – Avenix Fzco has unveiled ForexIGO, an advanced multi-market trading bot designed to automate strategies for both gold (XAUUSD) and the British pound against the US dollar (GBPUSD), offering traders a streamlined approach to diversification. Automated trading has come a long way, versatility matters more than ever. Traders are increasingly looking beyond single-market bots and toward solutions that can handle multiple assets at once. This shift has sparked growing interest in multi-market trading bots – systems designed to navigate different markets simultaneously, spreading risk and boosting opportunity. One such tool is ForexIGO, developed by Avenix Fzco, which brings together smart automation for both gold (XAUUSD) and the British pound against the US dollar (GBPUSD). Why Multi-Market Trading Bots Are Gaining Ground Traditional trading bots often zeroed in on a single market or asset. Today, though, financial markets move fast and unpredictably, pushing the rise of bots that can handle multiple asset classes. This approach helps traders spread risk and seize opportunities across a wider landscape, less reliance on one market, more room to adapt. Dual-Asset Focus with Practical Precision ForexIGO is carefully crafted to trade both XAUUSD and GBPUSD on the M30 timeframe. This dual-asset focus gives traders the ability to shift between markets based on conditions or strategy, offering greater control and the potential for stronger returns. It’s a practical way to diversify without overcomplicating the process. How ForexIGO Makes It Work It stands out for its smart market analysis, decoding price action, indicators, and candlestick patterns like bullish or bearish engulfing to deliver clear, confident trade signals. Built-In Risk Controls for Real-World Markets Capital preservation remains central to ForexIGO’s strategy. Stop-loss and take-profit ratios are tailored to each market: for gold, the take profit is set at 1.5 times the stop loss, striking a thoughtful balance. For GBPUSD, it opts for a 1:1 ratio, tailored to the pair’s dynamics. This structured approach maximizes potential gains while keeping losses in check. Smart Limits and Continuous Monitoring To prevent overexposure, ForexIGO limits active positions, handling one gold position at a time and up to four concurrent GBP/USD trades. Its 24/5 monitoring ensures it remains alert across market sessions, offering consistent oversight without requiring the trader to be glued to a screen. Looking Ahead As traders move toward diversification and smarter automation, tools like ForexIGO offer a balanced, hands-on approach to navigating complex markets, without adding extra complexity. About ForexIGO ForexIGO delivers cutting-edge trading solutions, empowering traders to navigate the complexities of Gold and GBP/USD markets with precision. Backed by a team of market experts and algorithmic specialists, ForexIGO continuously evolves, leveraging innovation to provide a competitive edge. Learn more at https://forexigo.com/. Media contact Brand: ForexIGO Contact: PR team Email: support@forexigo.com Website: https://forexigo.com/
Hua Medicine Announces 2024 Annual Results
- HuaTangNing completed its first full year for reimbursement under the National Reimbursement Drug List (NRDL), with continued expansion in hospital coverage. Compared with the 2023 year, sales volume increased by approximately 740%.- Sales revenue increased by 234% compared with the 2023 year, with cash reserves exceeding RMB 1 billion to fully support future R&D and commercialization activities.- A Phase I clinical study of our second-generation GKA, a once daily oral therapy, successfully completed in the United States. Our dorzagliatin-metformin fixed-dose combination formulation progressed smoothly and our product pipeline continued to advance and expand.- The Mendelian Randomization studies of human genetic data provided scientific evidence to support the exploration of glucokinase activation in diabetic complications and new clinical indications.- Manufacturing capacity of dorzagliatin continued to expand to meet growing market demand.- The establishment of Hua Medicine’s pharmaceutical sales and marketing team resulted in significant sales growth in the first two months of 2025, opening a new model of innovative drug commercialization.SHANGHAI, Mar 28, 2025 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (“the Company”, Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the “Reporting Period”), along with the Company’s business progress in 2024 and future business outlook. Hua Medicine has made significant strides in the commercialization of its core product, the glucokinase activator (GKA) dorzagliatin (trade name: HuaTangNing, as well as in R&D innovation and manufacturing capacity optimization, laying a solid foundation for the Company’s long-term sustainable development.Dr. Li Chen, Founder and the Chief Executive Officer of Hua Medicine, stated: “In 2024, HuaTangNing’s market performance was very encouraging. Its inclusion in the NRDL greatly enhanced the accessibility and affordability of this innovative drug, enabling more diabetes patients to benefit. In 2025, Hua Medicine established a pharmaceutical sales and marketing team, and HuaTangNing demonstrated strong growth momentum at the start of the year. With further market expansion and increasing patient awareness, we are confident in HuaTangNing’s market growth.”“Looking ahead, the Company will continue to explore HuaTangNing’s potential in personalized diabetes treatment and diabetes complications globally. By integrating big data and artificial intelligence technologies, we aim to expand our disease areas into immune homeostasis and neural homeostasis. We are confident with the close collaboration of Hua Medicine and its partners across the pharmaceutical R&D, production, and distribution chain, we can enable more patients to access and benefit from Chinese medicines, accelerating progress in realizing our vision ‘China leading pharmaceutical innovation to advance human health.’”Summary of Clinical Research and Operational Progress- Significant Revenue Growth, Strong Market Performance of HuaTangNing, and Positive Patient Feedback- 2024 marked the first full year for which our HuaTangNing was reimbursed under the National Reimbursement Drug List (“NRDL”) in China. Sales revenue increased by 234% to RMB255.9 million for the fiscal year 2024 compared with the same period in 2023. During the fiscal year 2024, HuaTangNing was sold in approximately 2,700 hospitals across China. As of December 31, 2024, Hua Medicine maintained a strong balance sheet with a cash balance of RMB1,139.8 million to support its full-scale commercialization, business development and R&D functions.- Since the launch of HuaTangNing in the fourth quarter of 2022, our pharmacovigilance team has been diligently monitoring the safety of dorzagliatin in the China market, and was recently recognized by the National Adverse Drug Reaction Monitoring Center as a national example for the pharmaceutical industry. As of December 31, 2024, Hua Medicine had monitored approximately 150,000 patients who have been prescribed HuaTangNing, and dorzagliatin has been observed to be safe and well tolerated by patients.- Effective January 1, 2025, Hua Medicine assumed full responsibility for the commercialization of HuaTangNing in China from its former sales and marketing partner, Bayer Healthcare Company Limited (“Bayer”). We recruited Mr. Lu Yu, a seasoned pharmaceutical sales executive with over 20 years of diabetes commercialization experience in China, to lead our sales and marketing efforts.- For the two months ended February 28, 2025, Hua Medicine sold approximately 592,000 packs of HuaTangNing, representing approximately RMB73.2 million in net sales. During the same period in 2024, approximately 202,000 packs of HuaTangNing were sold, representing approximately RMB24.5 million in net sales, The difference represents a significant increase in sales over a period during which the price per pack remained the same. This demonstrates a smooth transition of HuaTangNing’s commercialization in China from Bayer to Hua Medicine, with reinvigorated growth momentum.- Upon the termination of the Exclusive Promotion Service Agreement, the unamortized contact liabilities amounting to RMB1,243,499,000 were released to profit or loss, and will be recognized as a gain in 2025 by the Group. Both parties have confirmed in a signed letter that there are no outstanding matters arising from such termination, nor does either party owe the other party any obligation or liabilities from such separation.- Steady Progress in R&D Innovation, Continuously Enriching Product Pipeline- Hua Medicine made significant headway in preparing the future expansion of our glucokinase-targeted, glucose homeostasis-centered therapy into the international markets, specifically the United States. We successfully completed and announced the results of its single-ascending dose (“SAD”) study in the United States of our second generation GKA (HM-002-1005), in which we validated the feasibility of dorzagliatin as a once daily oral therapy for Type 2 diabetes (“T2D”) patients. We are currently developing the clinical dosage form for advancement of HM-002-1005 in a clinical proof-of-mechanism study.- Hua Medicine also made significant progress in developing fixed-dose combination formulations. The Company has been advancing its dorzagliatin-metformin fixed-dose combination product candidate into commercial dosage development, with process validation expected to be completed in 2025.- Based on human genetic data collected from studies of patients administered with dorzagliatin, the Mendelian Randomization methodology has been applied to predict the beneficial effects of dorzagliatin on related and significant diabetes complications, such as reduction in heart failure, coronary artery disease, memory loss and dyslipidemia. In addition, a separate Mendelian Randomization study provided genetic evidence supporting the causal effects of glucokinase activation on lowering the risk of frailty. These findings suggest that glucokinase activators may aid in the management of frailty and sarcopaenia in people with diabetes. We will continue our research and development efforts to explore new indications.- Through our SENSITIZE 3 clinical study in Hong Kong, Hua Medicine is advancing the potential of dorzagliatin in prediabetes, early treatment and prevention of Type 2 diabetes. In contrast with the approved 75mg dosage form of HuaTangNing, the Company is testing new 25mg and 50mg dosage formulations to explore these potential new indications. The Company is also supporting an investigator-sponsored trial in testing dorzagliatin’s efficacy in treating MODY-2 patients who suffered from genetic mutations that de-activated glucokinase. Early studies in humans by renowned diabetes experts Dr. Juliana Chan and Dr. Linong Ji have indicated the benefit of dorzagliatin in MODY-2 patients by improving their β-cell functions and glycemic control.- Hua Medicine is also advancing the combination of dorzagliatin with GLP-1RA, DPP-IV inhibitors and SGLT-2 inhibitor through combined effects in collecting real-world evidence and proof-of-concept studies in animal models. The synergy between dorzagliatin with these agents has the potential to expand our indication into other diseases in metabolic disorders, such as obesity and MASH. - Hua Medicine will continue our engagement in diabetes prevention, opportunities in longevity and prevention of memory loss and eventually find a new way to increase healthy life span and longevity in humans.- Continued Expansion of Manufacturing Capacity, Plans to Launch Dorzagliatin in New Markets- Hua Medicine continues to invest in expanding its manufacturing capacity to meet anticipated market needs in 2026 and 2027.- Hua Medicine is also finalizing and preparing to submit registration applications for dorzagliatin to launch commercialization in the Macau and Hong Kong markets. We plan to submit both applications in 2025.- Hua Medicine continues to strengthen its intellectual property protection globally. As of December 31, 2024, the Company owned more than 200 granted patents covering its proprietary technology worldwide.Business outlook- There is a great opportunity for dorzagliatin and our 2nd generation GKA in China and the global oral anti-diabetes market. - We will strengthen our own commercialization efforts through hub and spoke development with focus on building up a strong internal sales and medical marketing organization to drive business growth in 2025. This will allow us to rebuild our strong connections directly to the medical community and better promote HuaTangNing in China and surrounding areas.- We continue to invest into digital technology platforms to create synergies across functions and enhance branding opportunities using AI technology.- We are working on the registration of dorzagliatin in HK and Macau region and engage partnerships in Southeastern Asia and Belt and Road nations. In addition, business development work on our 2nd generation GKA in regions with high incidences of obesity will be continued based on the initial success of the SAD study in the United States.Financial SummaryFor the year ended December 31, 2024:- Bank balances and cash position was approximately RMB1,139.8 million.- Total revenue was approximately RMB255.9 million, an increase of approximately 234% compared to the full year of 2023; approximately 2,105,000 packs of HuaTangNing were sold, an increase of approximately 740% compared to the full year of 2023.- Total other income was approximately RMB116.8 million, including approximately RMB95.7 million from the amortization of Bayer milestone income.- Total expenditures for the year was approximately RMB493.6 million, of which R&D expenses accounted for approximately RMB215.1 million.- Loss before tax was approximately RMB250.1 million, which was mainly attributable to the increase of selling expense and research and development expense.Forward-Looking StatementsThis document contains statements regarding Hua Medicine’s future expectations, plans, and prospects for the Company and its products. These forward-looking statements pertain only to events or information as of the date they are made and may change due to future developments. Unless required by law, we are not obligated to update or publicly revise any forward-looking statements or unexpected events after the date of such statements, regardless of new information, future events, or other circumstances. Please read this document carefully and understand that our actual future performance or results may differ materially from expectations due to various risks, uncertainties, or other legal requirements.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing(dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more information Hua MedicineWebsite:www.huamedicine.comInvestorsEmail:ir@huamedicine.comMediaEmail:pr@huamedicine.comPress DisclaimerFor accuracy and completeness in context, information related to products marketed in China in this material, especially those identified or required, should comply with documents approved by Chinese regulatory authorities.Additionally, such information should not be interpreted as a recommendation or promotion of any drug or treatment, nor should it replace medical advice from healthcare professionals. For medical-related matters, please consult a healthcare professional. Copyright 2025 ACN Newswire via SeaPRwire.com.
Analogue FY2024 Revenue Rose to HK$6,450 Million with Adjusted Profit Attributable to Owners of the Company Increased to HK$206 Million
HONG KONG, Mar 28, 2025 - (ACN Newswire via SeaPRwire.com) - Analogue Holdings Limited (“Analogue” or the “Company”, together with its subsidiaries, the “Group”) (stock code: 1977), a leading provider of electrical and mechanical (“E&M”) engineering solutions, and information and communications technology services for smart cities, today announced its annual results for the year ended 31 December 2024 (the “Year” or “FY2024”).Financial Highlights- Contracts-in-hand remained at a high level of HK$11,052.7 million- Revenue rose to HK$6,450.1 million, up 5.2% year-on-year- Adjusted profit attributable to owners of the company recorded HK$206.0 million 1 with a growth of 10.2% 2 year-on-year, excluding a one-off expense and provision- Total dividend for the year amounted to HK4.38 cents per shareChairman Dr Mak Kin Wah said, “Capturing opportunities from shifting market priorities towards intelligent and digital solutions, data centres, environmental engineering and climate solutions, hospitals, infrastructure, and housing, we maintained a high level of contracts-in-hand across the Group’s diverse scope of business, providing a strong underlying foundation for the business over the next two years and beyond; this was notwithstanding the challenges around the world and in Hong Kong during the year.ATAL Tower, our new headquarters, is a significant investment that demonstrates our confidence in the future and our commitment to Hong Kong. We will continue to leverage our expertise and strong financial position to take up additional opportunities in the Hong Kong market, and explore further business development in overseas markets. Our investment in research and development, and innovation will enhance our core strengths and competitiveness. We will tirelessly live up to our motto of ‘We Commit. We Perform. We Deliver.’, ultimately driving our sustainable growth, optimising value for shareholders and other stakeholders, and contributing to the wider community.”Business Review: Building Services- This segment is the largest revenue contributor, with revenue up 5.3% to HK$3,933 million.- The recurring maintenance revenue increased by 40.2% to HK$422 million.- Leadership in the innovative construction technology of Multi-trade Integrated Mechanical, Electrical and Plumbing (“MiMEP”) received a major boost during the year, not only with the award of significant contract for a Grade A office building in Causeway Bay with the highest level of MiMEP application at 85% for a commercial building, but also with the development of our own systematic MiMEP methodologies and solutions.- The “MiMEP Design and Manufacturing Centre” and “MiMEP High Productivity Research Centre” in Zhuhai, as well as other MiMEP manufacturing facilities in Hong Kong, were established to integrate our capabilities in the Greater Bay Area with cutting-edge technology from Hong Kong.Environmental Engineering- The order intake significantly increased by 107.4% to HK$1,514 million, with contracts won for environmental infrastructure needed to enhance climate resilience, environmental protection, sustainability of water supply and waste treatment, and support for public housing and utilities.- The segment actively extended its expert services around the world, including Teresa in the Philippines, Dubai and other parts of the world.Information, Communications and Building Technologies (“ICBT”)- The order intake increased 22.5% to HK$757 million, with contracts-in-hand up 13.8% to HK$959 million.- The segment actively collaborated with leading manufacturers worldwide and in Mainland China to expand its technology reach and deliver cutting-edge solutions in diverse sectors.Lifts and Escalators- There was a significant growth in order intake and revenue, up 48.5% to HK$548 million and up 39.9% to HK$529 million respectively.- The two recently acquired lift companies in the United Kingdom (“UK”) contributed to revenue growth and made progress in the UK business.- The associate in the United States turned from a loss to a profit in FY2024 and made progress in expanding its business into additional cities in the South.For further details of the 2024 Annual Results, please refer to the announcement filed with The Stock Exchange of Hong Kong Limited.Remark:1. Profit attributable to the owners of the Company was HK$135.3 million, including a one-off expense of approximately HK$23.1 million before tax for relocation to the new consolidated headquarters to realise enhanced efficiency and synergy across business units, and a provision for expected credit loss of HK$88.0 million before tax to reflect risks with the recoverability of certain receivables and contract assets held by the Group in relation to certain construction companies.2. When compared with the adjusted profit attributable to owners of the company of HK$186.9 million in FY2023, which excludes a one-off dilution gain before tax upon completion of a private placement by an associate in Mainland China, a gain on disposal of interest before tax in an associate, and a provision before tax in respect of certain contracts in the healthcare sector.About Analogue Holdings LimitedEstablished in 1977, Analogue Holdings Limited is a leading provider of electrical and mechanical (“E&M”) engineering solutions and information and communications technology (“ICT”) services for smart cities, with headquarters in Hong Kong and operations in Macau, Mainland China, the United States and the United Kingdom. Serving a wide spectrum of customers from public and private sectors, the Group provides multi-disciplinary and comprehensive E&M engineering and technology services in four major segments, including Building Services, Environmental Engineering, Information, Communications and Building Technologies (“ICBT”) and Lifts & Escalators.The Group also manufactures and sells Anlev lifts and escalators internationally and has entered into an alliance with Transel Elevator & Electric Inc. (“TEI”), one of the largest independent lifts and escalators companies in New York, the United States. The Group’s associate partner, Nanjing Canatal Data-Centre Environmental Tech Co., Ltd (603912.SS), specialises in manufacturing of precision air conditioners. Copyright 2025 ACN Newswire via SeaPRwire.com.
Mitsubishi Corporation, ADM Sign Non-Binding MOU, Form Strategic Alliance
TOKYO, Mar 28, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Corporation and ADM are pleased to announce that both companies have signed a non-binding memorandum of understanding to form a strategic alliance to explore potential areas of future collaboration across the agriculture value chain.In recent years, the importance of secure and resilient food and agriculture supply chains has come into sharper focus, driven both by short-term dislocations as well as structural demand shifts powered by global population growth, economic development, and increasing consumer preference for sustainably sourced products. It has thus become essential to adopt a comprehensive and cross-industrial approach, connecting multiple businesses in different segments to address these challenges.Building on their long relationship, MC and ADM now will explore potential new ways to bring their respective strengths together to meet these global challenges.MC offers a cross-industrial business platform spanning multiple industries including food and energy, with ADM offering the capabilities of one of the world's largest food and agriculture companies. The companies hope that these broad and deep capabilities will allow them to create value by identifying new opportunities to meet global needs ranging from a robust biofuel supply chain to a stronger, more resilient global food system.Together, MC and ADM are committed to creating value and driving solutions that will help shape the future of the global agriculture value chain. Copyright 2025 JCN Newswire via SeaPRwire.com.
2025孤独星球 – 星光跑：用爱点亮”星星的孩子”未来
深圳, 2025年3月28日 - (亚太商讯 via SeaPRwire.com) - 由深圳市残联和龙华区人民政府指导，区残工委主办、区残联承办的"孤独星球 - 星光跑"公益活动将于3月30日上午在深圳龙华人才绿道群贤广场正式开跑。本次活动旨在提升社会对自闭症群体的认知，推动社会各界共同为他们构建更加友好的成长环境。作为本次活动的主要协办单位，深圳海纳特教集团正积极筹备，号召自闭症儿童及家长、特教从业者和社会各界爱心人士踊跃参与。孤独症，又称自闭症，是一种广泛性发育障碍，主要表现为社交障碍、语言沟通困难和刻板行为模式。世界卫生组织（WHO）数据显示，全球每100名儿童中就有1名被诊断为孤独症。为提高公众对这一群体的关注度，联合国自2008年起将每年的4月2日设立为"世界自闭症关注日"。今年的孤独星球-星光跑，正是为了在世界自闭症关注日前夕，通过运动和公益行动，让更多人了解并接纳自闭症群体。海纳特教集团创始人郭洁波携手同行"孤独星球-星光跑"，用爱点亮星光本次星光跑活动，社会各界爱心人士和企业积极响应，踊跃报名参与并提供支持。活动将在3月30日早上7:30进行签到和物资领取，并于8:30正式开跑。参与者将通过奔跑与陪伴，让自闭症儿童及其家庭感受到社会的温暖与关怀。"我们希望不仅仅是为孤独症儿童提供康复和教育服务，更要让社会认识到，他们的成长和发展需要社会各界共同努力。"郭洁波先生补充道，"同时，我们也希望吸引更多投资者关注特殊儿童教育产业，这不仅具有重要的社会价值，也蕴藏着可持续发展的经济潜力。"未来，海纳特教集团将持续深化在孤独症康复教育领域的探索，为更多特殊儿童及其家庭带去希望与改变。关于中国自闭症儿童康复事业的可持续发展近年来，中国自闭症儿童康复和教育行业逐步发展，社会关注度不断提升。然而，行业仍面临专业人才短缺、服务资源分布不均、长期资金支持不足等挑战。根据《中国自闭症教育康复行业发展状况报告》，我国孤独症群体已超过1000万人，其中儿童超过200万。海纳特教集团创始人郭洁波先生表示："特殊儿童教育不仅是一项公益事业，更是具备长期可持续发展的社会产业。随着社会认知的提升和政府政策的支持，行业正在从单一的康复培训模式向'康复+教育+就业'的多元化方向发展，为投资者提供了可观的经济回报。"他进一步指出："当前，社会资本的进入将加速行业的标准化和规模化，提升服务质量，同时推动技术创新，如智能辅助康复设备、AI特教平台等，使更多孤独症儿童获得更高效的成长支持。这不仅有助于解决社会问题，也能带来稳定的长期收益。"未来，随着政府、社会组织及市场资本的共同推动，中国自闭症康复与教育行业将迎来更广阔的发展前景，实现经济效益与社会效益的双赢。构建自闭症儿童全生涯支持体系海纳特教集团创始人郭洁波先生表示："孤独症儿童被称为'星星的孩子'，他们的成长离不开社会的支持。海纳希望通过此次星光跑活动，让社会各界更加关注这一特殊群体，促进自闭症人士的社会融合。"为了帮助孤独症群体实现更好的发展，海纳于2019年创办了"海纳星智梦工场"，整合特教康复、职业培训与就业支持，探索"康复教育+职前培训+就业支持"的发展模式。在龙华区民政局的支持下，海纳还注册成立了深圳市龙华区海纳儿童康复中心，为孤独症儿童提供从学龄期到职前技能培训、再到就业支持的全链条服务，助力他们更好地融入社会。关于海纳特教集团海纳特教集团成立于2009年，致力于为心智障碍者提供涵盖早期干预、融合教育、职业培训、支持性就业等在内的全生涯服务。截至目前，海纳已为5000多名心智障碍人士提供支持，在深圳乃至整个大湾区享有良好声誉。自2009年成立以来，海纳不断拓展服务体系，包括发育评估、早期康复、融合教育、职业技能培训、支持性就业等，帮助孤独症群体更好地融入社会，提升生活质量。了解更多，请关注http://hainatejiao.com/媒体联络品牌：深圳海纳特教集团联系：媒体团队电话：(+86)18025411773网站：http://hainatejiao.com/ Copyright 2025 亚太商讯 via SeaPRwire.com.